Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction (Developmental Neuroscience DOI: 10.1159/000150127);Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction

Developmental Neuroscience

Volumn 30, Issue 5, 2008, Pages 340-357

  Givogri, M I ^a,f   Bottai, D ^b   Zhu, H L ^a   Fasano, S ^c   Lamorte, G ^b   Brambilla, R ^c   Vescovi, A ^d   Wrabetz, L ^e   Bongarzone, E ^a,f  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Stem Cell Research Institute   (Italy)

^e Department of Molecular Biology and Functional Genomics ^*  (Italy)

^f SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Leukodystrophy; Lysosomal storage disease; Myelin; Neurodegeneration; Neurospheres; Precursors

Indexed keywords

CEREBROSIDE SULFATASE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; SULFATIDE;

ADOLESCENT; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DYSFUNCTION; CELL THERAPY; CONTROLLED STUDY; ENZYME ACTIVITY; LEARNING DISORDER; METACHROMATIC LEUKODYSTROPHY; MOTOR DYSFUNCTION; MOUSE; NERVE DEGENERATION; NEURAL STEM CELL; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL;

EID: 52949138244     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000159456     Document Type: Erratum

References (65)

1. Gieselmann V: Metachromatic leukodystrophy: recent research developments. J Child Neurol 2003;18:591-594.
2. Wenger D, Suzuki K, Suzuki Y, Suzuki K: Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease);in Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill, 2001, pp 3669, 3670, 3687.
3. Matalon R, Kaul R, Michals K: Canavan disease: biochemical and molecular studies. J Inherit Metab Dis 1993;16:744-752.
4. Givogri MI, Galbiati F, Fasano S, et al: Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci 2006;26:3109-3119.
5. Snyder EY, Taylor RM, Wolfe JH: Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 1995;374:367-370.
6. Yandava BD, Billinghurst LL, Snyder EY: 'Global' cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 1999;96:7029-7034.
7. Windrem MS, Nunes MC, Rashbaum WK, et al: Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004;10:93-97.
8. Alvarez-Buylla A, Lim DA: For the long run: maintaining germinal niches in the adult brain. Neuron 2004;41:683-686.
9. Gage FH, Ray J, Fisher LJ: Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 1995;18:159-192.
10. Akerud P, Canals JM, Snyder EY, Arenas E: Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J Neurosci 2001;21:8108-8118.
11. Svendsen CN, Langston JW: Stem cells for Parkinson disease and ALS: replacement or protection? Nat Med 2004;10:224-225.
12. Pluchino S, Quattrini A, Brambilla E, et al: Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003;422:688-694.
13. Park KI, Lachyankar M, Nissim S, Snyder EY: Neural stem cells for CNS repair: state of the art and future directions. Adv Exp Med Biol 2002;506:1291-1296.
14. Pluchino S, Zanotti L, Rossi B, et al: Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005;436:266-271.
15. Mueller FJ, McKercher SR, Imitola J, et al: At the interface of the immune system and the nervous system: how neuroinflammation modulates the fate of neural progenitors in vivo. Ernst Schering Res Found Workshop 2005;53:83-114.
16. Imitola J, Raddassi K, Park KI, et al: Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004;101:18117-18122.
17. Jin K, Sun Y, Xie L, et al: Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol Dis 2005;18:366-374.
18. Lee JP, Jeyakumar M, Gonzalez R, et al: Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat Med 2007;13:439-447.
19. Fukuhara Y, Li XK, Kitazawa Y, et al: Histopathological and behavioral improvement of murine mucopolysaccharidosis type VII by intracerebral transplantation of neural stem cells. Mol Ther 2006;13:548-555.
20. Kawabata K, Migita M, Mochizuki H, et al: Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. Brain Res 2006;1094:13-23.
21. Klein D, Schmandt T, Muth-Kohne E, et al: Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy. Gene Ther 2006;13:1686-1695.
22. Hess B, Kafert S, Heinisch U, Wenger DA, Zlotogora J, Gieselmann V: Characterization of two arylsulfatase A missense mutations D335V and T274M causing late infantile metachromatic leukodystrophy. Hum Mutat 1996;7:311-317.
23. Givogri MI, de Planell M, Galbiati F, et al: Notch signaling in astrocytes and neuroblasts of the adult subventricular zone in health and after cortical injury. Dev Neurosci 2006;28:81-91.
24. Luca T, Givogri MI, Perani L, et al: Axons mediate the distribution of arylsulfatase A within the mouse hippocampus upon gene delivery. Mol Ther 2005;12:669-679.
25. Franklin RJ, Bayley SA, Blakemore WF: Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord. Exp Neurol 1996;137:263-276.
26. Meng XL, Shen JS, Ohashi T, Maeda H, Kim SU, Eto Y: Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. J Neurosci Res 2003;74:266-277.
27. Bongarzone ER, Campagnoni CW, Kampf K, et al: Identification of a new exon in the myelin proteolipid protein gene encoding novel protein isoforms that are restricted to the somata of oligodendrocytes and neurons. J Neurosci 1999;19:8349-8357.
28. Schmued LC, Hopkins KJ: Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000;874:123-130.
29. Vescovi AL, Parati EA, Gritti A, et al: Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol 1999;156:71-83.
30. Wittke D, Hartmann D, Gieselmann V, Lullmann-Rauch R: Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution. Acta Neuropathol 2004;108:261-271.
31. Neufeld EF, Fratantoni JC: Inborn errors of mucopolysaccharide metabolism. Science 1970;169:141-146.
32. Passini MA, Lee EB, Heuer GG, Wolfe JH: Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream. J Neurosci 2002;22:6437-6446.
33. D'Hooge R, Van Dam D, Franck F, Gieselmann V, De Deyn PP: Hyperactivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy. Brain Res 2001;907:35-43.
34. Consiglio A, Quattrini A, Martino S, et al: In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat Med 2001;7:310-316.
35. Felling RJ, Snyder MJ, Romanko MJ, et al: Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia. J Neurosci 2006;26:4359-4369.
36. De Filippis L, Lamorte G, Snyder EY, Malgaroli A, Vescovi AL: A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem Cells 2007;25:2312-2321.
37. Horner PJ, Thallmair M, Gage FH: Defining the NG2-expressing cell of the adult CNS. J Neurocytol 2002;31:469-480.
38. Sevin C, Benraiss A, Van Dam D, et al: Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy. Hum Mol Genet 2006;15:53-64.
39. Yaghootfam A, Gieselmann V, Eckhardt M: Delay of myelin formation in arylsulphatase A-deficient mice. Eur J Neurosci 2005;21:711-720.
40. Saravanan K, Schaeren-Wiemers N, Klein D, et al: Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder. Neurobiol Dis 2004;16:396-406.
41. Weerachatyanukul W, Probodh I, Kongmanas K, Tanphaichitr N, Johnston LJ: Visualizing the localization of sulfoglycolipids in lipid raft domains in model membranes and sperm membrane extracts. Biochim Biophys Acta 2007;1768:299-310.
42. Joannides AJ, Webber DJ, Raineteau O, et al: Environmental signals regulate lineage choice and temporal maturation of neural stem cells from human embryonic stem cells. Brain 2007;130:1263-1275.
43. Lepore AC, Fischer I: Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord. Exp Neurol 2005;194:230-242.
44. Harrower TP, Tyers P, Hooks Y, Barker RA: Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease. Exp Neurol 2006;197:56-69.
45. Meissner KK, Kirkham DL, Doering LC: Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's. Brain Res 2005;1057:105-112.
46. Lepore AC, Han SS, Tyler-Polsz CJ, Cai J, Rao MS, Fischer I: Differential fate of multipotent and lineage-restricted neural precursors following transplantation into the adult CNS. Neuron Glia Biol 2004;1:113-126.
47. Lepore AC, Neuhuber B, Connors TM, et al: Long-term fate of neural precursor cells following transplantation into developing and adult CNS. Neuroscience 2006;142:287-304.
48. Taylor RM, Lee JP, Palacino JJ, et al: Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy. J Neurochem 2006;97:1585-1599.
49. Zhao G, McCarthy NF, Sheehy PA, Taylor RM: Comparison of the behavior of neural stem cells in the brain of normal and twitcher mice after neonatal transplantation. Stem Cells Dev 2007;16:429-438.
50. Campos LS, Decker L, Taylor V, Skarnes W: Notch, epidermal growth factor receptor, and beta1-integrin pathways are coordinated in neural stem cells. J Biol Chem 2006;281:5300-5309.
51. Tanigaki K, Nogaki F, Takahashi J, Tashiro K, Kurooka H, Honjo T: Notch1 and Notch3 instructively restrict bFGF-responsive multipotent neural progenitor cells to an astroglial fate. Neuron 2001;29:45-55.
52. Ge W, Martinowich K, Wu X, et al: Notch signaling promotes astrogliogenesis via direct CSL-mediated glial gene activation. J Neurosci Res 2002;69:848-860.
53. Nakashima K, Yanagisawa M, Arakawa H, Taga T: Astrocyte differentiation mediated by LIF in cooperation with BMP2. FEBS Lett 1999;457:43-46.
54. Bonaguidi MA, McGuire T, Hu M, Kan L, Samanta J, Kessler JA: LIF and BMP signaling generate separate and discrete types of GFAP-expressing cells. Development 2005;132:5503-5514.
55. Albrecht PJ, Dahl JP, Stoltzfus OK, Levenson R, Levison SW: Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp Neurol 2002;173:46-62.
56. Song MR, Ghosh A: FGF2-induced chromatin remodeling regulates CNTF-mediated gene expression and astrocyte differentiation. Nat Neurosci 2004;7:229-235.
57. Levison SW, Jiang FJ, Stoltzfus OK, Ducceschi MH: IL-6-type cytokines enhance epidermal growth factor-stimulated astrocyte proliferation. Glia 2000;32:328-337.
58. D'Alessandro JS, Yetz-Aldape J, Wang EA: Bone morphogenetic proteins induce differentiation in astrocyte lineage cells. Growth Factors 1994;11:53-69.
59. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA: Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 1996;17:595-606.
60. Mabie PC, Mehler MF, Marmur R, Papavasiliou A, Song Q, Kessler JA: Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial- astroglial progenitor cells. J Neurosci 1997;17:4112-4120.
61. Fuller ML, DeChant AK, Rothstein B, et al: Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions. Ann Neurol 2007;62:288-300.
62. Buk DM, Waibel M, Braig C, Martens AS, Heinrich PC, Graeve L: Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells. J Cell Sci 2004;117:2063-2075.
63. Buk DM, Renner O, Graeve L: Increased association with detergent-resistant membranes/lipid rafts of apically targeted mutants of the interleukin-6 receptor gp80. Eur J Cell Biol 2005;84:819-831.
64. Kim J, Adam RM, Solomon KR, Freeman MR: Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells. Endocrinology 2004;145:613-619.
65. Satow R, Kurisaki A, Chan TC, Hamazaki TS, Asashima M: Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction. Dev Cell 2006;11:763-774.